We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
-17.94%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$37.2B
AUM Growth
-$12.8B
(-26%)
Cap. Flow
-$1.76B
Cap. Flow
% of AUM
-4.73%
Top 10 Holdings %
Top 10 Hldgs %
50.93%
Holding
153
New
8
Increased
51
Reduced
61
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$387M |
| 2 |
Meta Platforms (Facebook)
META
|
+$341M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$280M |
| 4 |
Baidu
BIDU
|
+$129M |
| 5 |
Twilio
TWLO
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sony
SONY
|
+$500M |
| 2 |
RTX Corp
RTX
|
+$240M |
| 3 |
Gartner
IT
|
+$199M |
| 4 |
Alibaba
BABA
|
+$155M |
| 5 |
American Express
AXP
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Consumer Discretionary | 7.45% |
| 3 | Communication Services | 5.61% |
| 4 | Financials | 5.39% |
| 5 | Real Estate | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CALL
RingCentral
RNG
$5.28B
| $52.3M | 0.14% |
1,000,000
+250,000
| +33% | +$19M |
|
|
CFLT
102
DELISTED
Confluent
CFLT
| $49.5M | 0.13% |
2,128,679
-624,359
| -23% | -$16.8M |
|
103
GitLab
GTLB
$6.58B
| $48.4M | 0.13% |
911,206
+175,000
| +24% | +$8.14M |
|
104
Peloton Interactive
PTON
$2.49B
| $38.9M | 0.1% |
4,234,254
+677,929
| +19% | +$10.9M |
|
105
Marqeta
MQ
$1.66B
| $37.4M | 0.1% |
1,154,162
+105,400
| +10% | +$4.14M |
|
106
Cintas
CTAS
$81.3B
| $35.2M | 0.09% |
376,532
-726,480
| -66% | -$70.8M |
|
107
Keros Therapeutics
KROS
$221M
| $32.5M | 0.09% |
1,176,433
+270,000
| +30% | +$11.8M |
|
|
CERE
108
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $32M | 0.09% |
1,210,979
-486,397
| -29% | -$13.8M |
|
109
Zillow
Z
$7.56B
| $26.1M | 0.07% |
820,584
-1,567,765
| -66% | -$63M |
|
110
Schrodinger
SDGR
$1.36B
| $25.6M | 0.07% |
968,608
-16,204
| -2% | -$435K |
|
111
CALL
Coinbase
COIN
$40.5B
| $25.4M | 0.07% |
+540,000
| New | +$51.4M |
|
|
AKRO
112
DELISTED
Akero Therapeutics
AKRO
| $24.8M | 0.07% |
2,619,671
+200,000
| +8% | +$2.09M |
|
113
PMV Pharmaceuticals
PMVP
$63.5M
| $21.7M | 0.06% |
1,519,935
-79,618
| -5% | -$1.16M |
|
114
JFrog
FROG
$10.8B
| $20.5M | 0.06% |
973,069
-15,937
| -2% | -$334K |
|
|
IGMS
115
DELISTED
IGM Biosciences
IGMS
| $18.6M | 0.05% |
1,034,035
| – | – |
|
116
CALL
KraneShares CSI China Internet ETF
KWEB
$5.67B
| $16.4M | 0.04% |
500,000
-500,000
| -50% | -$14.4M |
|
117
Xometry
XMTR
$5.34B
| $15.5M | 0.04% |
457,621
+93,454
| +26% | +$3.22M |
|
|
RNAM
118
DELISTED
Avidity Biosciences
RNAM
| $12.4M | 0.03% |
856,466
| – | – |
|
119
BioCryst Pharmaceuticals
BCRX
$2.4B
| $12.4M | 0.03% |
1,168,345
-19,500
| -2% | -$201K |
|
120
Procore
PCOR
$8.67B
| $11.5M | 0.03% |
253,840
-4,281
| -2% | -$210K |
|
|
KLRS
121
Kalaris Therapeutics
KLRS
$96.8M
| $10.7M | 0.03% |
119,735
+86,956
| +265% | +$9.12M |
|
|
ALTR
122
DELISTED
Altair Engineering Inc
ALTR
| $10.2M | 0.03% |
193,919
-3,227
| -2% | -$176K |
|
123
Oric Pharmaceuticals
ORIC
$1.4B
| $9.44M | 0.03% |
2,106,968
+200,000
| +10% | +$798K |
|
124
Apple
AAPL
$4.57T
| $7.74M | 0.02% |
56,627
-984,651
| -95% | -$149M |
|
125
TG Therapeutics
TGTX
$7.62B
| $7.51M | 0.02% |
1,767,130
-30,880
| -2% | -$193K |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Alkeon Capital Management held 153 positions worth $37.2B, down 26% from $49.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Alkeon Capital Management withdrew a net $1.76B in Q2 2022, closing 9 positions and reducing 61 holdings. Its most notable exit was RTX Corp, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Alkeon Capital Management opened a new position in ASML worth $330M.
- Alkeon Capital Management's largest Q2 2022 buy was ASML: 693,681 shares worth $330M.
- Alkeon Capital Management added most to Meta Platforms (Facebook) in Q2 2022, an estimated $341M increase.
- Alkeon Capital Management's biggest Q2 2022 reduction was Sony, cutting an estimated $500M.
- Alkeon Capital Management fully exited RTX Corp in Q2 2022, selling an estimated $240M.
- Alkeon Capital Management's ten largest holdings make up 51% of its $37.2B portfolio in Q2 2022.
- Alkeon Capital Management opened 8 new positions and closed 9 in Q2 2022.
- Alkeon Capital Management's portfolio value fell 26% quarter-over-quarter to $37.2B.
Based on Alkeon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.